FDA: Johnson & Johnson's COVID-19 vaccine appears to meet requirements for emergency use
The FDA says Johnson and Johnson's COVID-19 vaccine meets all requirements for emergency use.
News 12 Staff
•
Feb 24, 2021, 11:12 PM
•
Updated 1,150 days ago
Share:
More Stories
Hometown Heroes in Connecticut
2ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
200ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
206ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
212ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
233ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
252ds agoHometown Heroes in Connecticut
2ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
200ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
206ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
212ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
233ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
252ds agoThe FDA says Johnson and Johnson's COVID-19 vaccine meets all requirements for emergency use.
It says Johnson & Johnson's COVID-19 vaccine is 66% effective at preventing COVID illness. That's compared to 95% for Pfizer and Moderna.
Dr. Manisha Juthani, an infectious disease physician with Yale Medicine, says that data hasn't been broken down by age yet but the shot could be more effective in younger age groups.
The Johnson & Johnson vaccine is also easier to store and administer. State officials say the federal government is hoping for 20 million doses of the Johnson & Johnson vaccine by the end of next month.
The shot is expected to be approved for use after Friday's hearing.
Juthani says the efficacy numbers shouldn't scare people off.
Juthani urges those 65 and up who haven't been vaccinated yet to sign up now before the eligibility pool gets much wider on Monday.
